Insomnia Treatment Market to Grow with a CAGR of 5.48% through 2030F
Rising advancements in pharmacological and
non-pharmacological treatments are expected to drive the Global Insomnia
Treatment Market growth in the forecast period, 2026-2030.
According to TechSci Research report, “Insomnia
Treatment Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Insomnia Treatment Market
stood at USD 3.12 billion in 2024 and is anticipated to grow with a CAGR of
5.48% in the forecast period, 2026-2030. The global insomnia treatment industry
is witnessing substantial growth, driven by a multitude of factors that are
reshaping the landscape of sleep medicine. Insomnia, characterized by
persistent difficulty falling asleep or staying asleep, affects millions of
individuals worldwide, impacting their quality of life and overall health. One
of the primary drivers behind the growth of the global insomnia treatment
market is the escalating prevalence of this sleep disorder. Stress, anxiety,
lifestyle changes, and the 24/7 digital age have all contributed to the
increasing incidence of insomnia
As more individuals seek treatment for their sleep
disturbances, the demand for insomnia treatment options continues to surge.
Increased awareness about the importance of sleep and its impact on overall
health has prompted more individuals to seek medical attention for their
sleep-related issues. Healthcare providers are becoming more adept at
recognizing and diagnosing insomnia, leading to more accurate reporting and
treatment. This rising awareness is catalyzing the growth of the insomnia
treatment market as people acknowledge the need for professional help in
managing their sleep disorders.
Pharmacological interventions have long been a cornerstone
of insomnia treatment, and recent advancements in this field have expanded
treatment options. Novel medications with improved safety profiles and efficacy
have entered the market, offering patients more choices for managing their
insomnia. Non-benzodiazepine sleep aids, melatonin agonists, and orexin
receptor antagonists are some examples of these innovative drugs that are
driving market growth. Cognitive-behavioral therapy for insomnia (CBT-I) has emerged
as a highly effective non-pharmacological treatment for insomnia. Unlike
medication, CBT-I addresses the underlying behavioral and psychological factors
contributing to insomnia. It has gained significant traction globally due to
its long-term effectiveness and minimal side effects. As healthcare providers
increasingly recognize the value of CBT-I, it is becoming more widely
available, contributing to the expansion of the global insomnia treatment
market.
Browse over XX market data Figures spread through XX
Pages and an in-depth TOC on "Global Insomnia Treatment Market”
The Global Insomnia Treatment Market is segmented into type,
drugs, distribution channel, regional distribution, and company.
Based on the Drugs, Zolpidem became the fastest-growing segment in the Global Insomnia Treatment Market in 2024. With a well-established track record for effectively treating insomnia, this non-benzodiazepine sedative-hypnotic acts on the central nervous system to induce sleep. Its widespread acceptance stems from the significant relief it provides to many individuals with insomnia.
Based on the distribution channel, the retail pharmacies
emerged as the dominant player in the global market for Global Insomnia
Treatment Market in 2022. Retail pharmacies are easily accessible to the
general population. They are typically located in neighborhoods, shopping
centers, and urban areas, making it convenient for individuals to visit and
purchase their prescribed insomnia medications. This accessibility ensures that
patients have a nearby source for their medication needs. retail
pharmacies have the infrastructure and expertise to process and fill
prescriptions promptly. When healthcare providers prescribe insomnia
medications, patients can take their prescription to a nearby retail pharmacy,
ensuring timely access to their treatment.
Based on region, Asia Pacific region is experiencing the fastest growth in
the global insomnia treatment market, driven by several key factors. The
increasing prevalence of insomnia, attributed to lifestyle changes,
work-related stress, and mental health issues, has heightened the demand for
effective treatments. The growing awareness about sleep health has led more
individuals to seek professional help for sleep disorders, expanding the
market. Technological advancements, such as wearable sleep trackers and mobile
health applications, have revolutionized insomnia management, making treatments
more accessible. Rising healthcare expenditure in countries like China, India,
and Japan further supports market expansion by improving access to healthcare
services. Collectively, these factors contribute to the rapid growth of the
insomnia treatment market in the Asia Pacific region.
Major companies operating in Global Insomnia Treatment
Market are:
- Merck
& Co
- Pfizer
Inc.
- Abbott
Laboratories
- Genentech
Inc.
- LGM
Pharma
- Sigma
Aldrich Corp.
- Sanofi
S.A
- Takeda
Pharmaceuticals Co. Ltd.
- Eisai
Ltd.
- Idorsia
Pharmaceuticals Apotex Corp
Download Free Sample Report
Customers can also request for 10% free customization on
this report.
“The global insomnia
treatment market is poised for substantial growth in the coming years, driven
by several key factors. The increasing prevalence of insomnia, fueled
by modern lifestyles, stress, and the rising incidence of comorbid conditions,
is creating a significant patient pool seeking treatment. This growing
awareness of the importance of sleep health is propelling individuals to seek
medical intervention for their sleep disturbances, boosting market demand.
Advancements in pharmacological and non-pharmacological treatments
are expanding the range of options available to patients. The development of
safer and more effective medications, as well as innovative behavioral
therapies, is enhancing treatment outcomes and patient satisfaction, further
stimulating market growth. A growing emphasis on mental health and well-being
is leading to integrated approaches to insomnia treatment. As the link between
insomnia and mental health becomes better understood, healthcare providers are
addressing both issues concurrently, broadening the scope of insomnia care.”
said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Insomnia
Treatment Market - Global Industry Size, Share, Trends, Opportunities and Forecast, Segmented By Type (Acute Insomnia Chronic Insomnia, Onset
Insomnia, Maintenance Insomnia, Behavioral Insomnia of Childhood), By Drugs
(Eszopiclone, Ramelteon, Zaleplon, Zolpidem, Estazolam, Others), By
Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online
Pharmacies) By Region and Competition 2020-2030F”, has
evaluated the future growth potential of Global Insomnia Treatment Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Insomnia Treatment Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New
York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com